New Study Reveals Natural Way to Regulate Blood Sugar Levels and Sugar Cravings
A groundbreaking new study suggests that scientists may have discovered a natural way to regulate blood sugar levels and sugar cravings, similar to the effects of drugs like Ozempic. The key to unlocking this natural process lies in a specific gut microbe and its metabolites – compounds produced during digestion, as revealed in research conducted on mice and humans.
The researchers, led by a team at Jiangnan University in China, demonstrated that by increasing the abundance of a particular gut microbe in diabetic mice, they could stimulate the secretion of glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone that plays a crucial role in regulating blood sugar levels and feelings of fullness, and its release is influenced by certain foods and gut microbes, similar to the mechanism of action of drugs like semaglutide (the active ingredient in Ozempic).
Individuals with type 2 diabetes often experience impaired GLP-1 function, leading to difficulties in blood sugar control. While drugs like Ozempic effectively mimic natural processes in the body, researchers are now exploring ways to enhance the body’s own production of GLP-1.
The study, published in Nature Microbiology, highlights the role of gut microbes like Bacteroides vulgatus and their metabolites in shaping a person’s preference for sweet foods. Experiments conducted on mice revealed that the absence of a specific gut protein, Ffar4, led to a decrease in the population of B. vulgatus, resulting in reduced secretion of the hormone FGF21, which is associated with sugar cravings.
Studies on mice treated with GLP-1 agonists have shown that these drugs stimulate the production of FGF21. Additionally, research on humans suggests that individuals with genetic variants related to FGF21 are more likely to have a high preference for sweet foods.
In a blood analysis involving participants with type 2 diabetes and healthy controls, mutations in Ffar4 were linked to reduced FGF21 production and an increased preference for sugar, potentially contributing to the development of diabetes. The researchers also found that treating mice with a metabolite of B. vulgatus increased GLP-1 secretion, leading to enhanced blood sugar control and reduced sugar cravings.
While the implications for humans are still being investigated, the study offers a promising strategy for diabetes prevention. By understanding the role of gut microbes and metabolites in regulating sugar preferences, researchers may uncover new ways to naturally manage blood sugar levels and combat sugar cravings.
This article was originally published in January 2025.
